RE:Another Publication Picked Up Concordia Drug Gauging StoryMcCrum article re-packaged. Increase in earnings 276% due to price increases and acquisitions (without providing weight or risk of acquisitions). Also: "Concordias price surge is reminiscent of a plot employed in the US last year by so-called bad boy of pharma Martin Shkreli, the founder of Turing Pharmaceuticals, who increased the cost of a medicine for Aids by 5,000 per cent." thereby implying something evil and sinister. This is clearly part of the short and distort effort. The short gain looks to make more money than Concordia WITHOUT providing any service to society.